Canada· CA-DIN-02538539
ONDEXXYA
A andexanet alfa product containing andexanet alfa, registered in Canada by ASTRAZENECA CANADA INC. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Andexanet alfa is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AB38 (andexanet alfa), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Andexanet alfa · ATC V03AB38
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ANDEXANET ALFA
- Manufacturer
- ASTRAZENECA CANADA INC
- Country
- Canada (CA)
- ATC code
- V03AB38
- ATC class
- Andexanet alfa
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Andexanet alfa in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandOndexxya 200 mg, Pulver zur Herstellung einer InfusionslösungAstraZeneca AG
- CzechiaONDEXXYAAstraZeneca AB, Södertälje
- FinlandOndexxyaAstraZeneca AB
- United KingdomOndexxya 200mg powder for solution for infusion vialsAstraZeneca UK Ltd
- IrelandOndexxya Powder for solution for infusionAstraZeneca AB
- IcelandOndexxyaAstraZeneca AB*
- Japanアンデキサネット アルファ（遺伝子組換え）アストラゼネカ
- NetherlandsOndexxya 200 mg poeder voor oplossing voor infusieAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ondexxya
- Liechtenstein · Ondexxya
- Norway · Ondexxya
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4abf320-3d3a-480c-9d58-fc323370f119 GET /v1/drugs/d4abf320-3d3a-480c-9d58-fc323370f119?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02538539",
"form": "POWDER FOR SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V03AB38",
"schedule": [
"Schedule D",
"Prescription"
],
"drug_code": "102725",
"strengths": [
"200 MG"
],
"ahfs_class": null,
"substances": [
"ANDEXANET ALFA"
],
"product_categorization": null
}See everything about andexanet alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.